ARC Group Attends M&A Worldwide Budapest

ARC Group Attends M&A Worldwide Budapest

On April 12 and 14, the 39th M&A Worldwide convention was held in Budapest. ARC Group, the exclusive member from Greater China, was represented by Xiaoyi (Isabella) Zuo who participated in the convention. The theme of the convention was for members and business guests to learn and discuss the latest developments and technology in the M&A industry.

Isabella was invited as a panelist speaker to share her views on current trends in the M&A industry, impacts, and ARC Group’s initiatives to use new technologies in M&A transactions. It was a great opportunity for members to discuss cross-border collaboration opportunities, network to build trust, and talk with local companies for cross-border activities.

Thank you M&A Worldwide for a great convention, and a pleasure to meet and connect with everyone.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission